Literature DB >> 11564372

Predisposing factors in the spondyloarthropathies: new insights into the role of HLA-B27.

R A Colbert1, S Prahalad.   

Abstract

Spondyloarthropathies represent complex genetic diseases whose development is influenced by environmental factors. Estimates suggest that three to nine loci may be responsible for the majority of the genetic susceptibility to ankylosing spondylitis. The only susceptibility locus identified to date in multiple populations is HLA-B, where several HLA-B27 alleles (subtypes) are strongly associated with disease. Recent evidence implicates cytochrome P450 2D6 as a second locus, although its influence on overall risk appears small. Despite considerable efforts to define how HLA-B27 contributes to disease, its role remains enigmatic. Increasing evidence suggests it has effects that are unrelated to its physiologic function. The basis for this is unknown but may be a consequence of the unusual tendency of this allele to misfold.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11564372     DOI: 10.1007/s11926-996-0011-9

Source DB:  PubMed          Journal:  Curr Rheumatol Rep        ISSN: 1523-3774            Impact factor:   4.592


  70 in total

Review 1.  Toll-like receptors in the induction of the innate immune response.

Authors:  A Aderem; R J Ulevitch
Journal:  Nature       Date:  2000-08-17       Impact factor: 49.962

2.  The -308.1 polymorphism in the promoter region of the tumor necrosis factor gene is associated with ankylosing spondylitis independent of HLA-B27.

Authors:  F McGarry; R Walker; R Sturrock; M Field
Journal:  J Rheumatol       Date:  1999-05       Impact factor: 4.666

3.  HLA-B27 modulates the survival of Salmonella enteritidis in transfected L cells, possibly by impaired nitric oxide production.

Authors:  M Virtala; J Kirveskari; K Granfors
Journal:  Infect Immun       Date:  1997-10       Impact factor: 3.441

4.  LMP2 polymorphism is associated with extraspinal disease in HLA-B27 negative Caucasian and Mexican Mestizo patients with ankylosing spondylitis.

Authors:  W P Maksymowych; S Tao; J Vaile; M Suarez-Almazor; C Ramos-Remus; A S Russell
Journal:  J Rheumatol       Date:  2000-01       Impact factor: 4.666

5.  HLA-B27 subtypes positively and negatively associated with spondyloarthropathy.

Authors:  A R Nasution; A Mardjuadi; S Kunmartini; N G Suryadhana; B Setyohadi; D Sudarsono; N M Lardy; T E Feltkamp
Journal:  J Rheumatol       Date:  1997-06       Impact factor: 4.666

6.  Role of the mouse ank gene in control of tissue calcification and arthritis.

Authors:  A M Ho; M D Johnson; D M Kingsley
Journal:  Science       Date:  2000-07-14       Impact factor: 47.728

7.  Naturally occurring A pocket polymorphism in HLA-B*2703 increases the dependence on an accessory anchor residue at P1 for optimal binding of nonamer peptides.

Authors:  T A Griffin; J Yuan; T Friede; S Stevanovic; K Ariyoshi; S L Rowland-Jones; H G Rammensee; R A Colbert
Journal:  J Immunol       Date:  1997-11-15       Impact factor: 5.422

8.  HLA-B27 as a relative risk factor in ankylosing enthesopathy in transgenic mice.

Authors:  S Weinreich; F Eulderink; J Capkova; M Pla; K Gaede; J Heesemann; L van Alphen; C Zurcher; B Hoebe-Hewryk; F Kievits
Journal:  Hum Immunol       Date:  1995-02       Impact factor: 2.850

9.  MICA gene triplet repeat polymorphism in patients with HLA-B27 positive and negative ankylosing spondylitis from Sardinia.

Authors:  L Ricci-Vitiani; A Vacca; I Potolicchio; R Scarpa; P Bitti; G Sebastiani; G Passiu; A Mathieu; R Sorrentino
Journal:  J Rheumatol       Date:  2000-09       Impact factor: 4.666

10.  The specificity of peptides bound to human histocompatibility leukocyte antigen (HLA)-B27 influences the prevalence of arthritis in HLA-B27 transgenic rats.

Authors:  M Zhou; A Sayad; W A Simmons; R C Jones; S D Maika; N Satumtira; M L Dorris; S J Gaskell; R S Bordoli; R B Sartor; C A Slaughter; J A Richardson; R E Hammer; J D Taurog
Journal:  J Exp Med       Date:  1998-09-07       Impact factor: 14.307

View more
  1 in total

Review 1.  HLA-B27-associated reactive arthritis: pathogenetic and clinical considerations.

Authors:  Inés Colmegna; Raquel Cuchacovich; Luis R Espinoza
Journal:  Clin Microbiol Rev       Date:  2004-04       Impact factor: 26.132

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.